There were 1,626 press releases posted in the last 24 hours and 359,451 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image